Will a drug company pay >$1m in a class action suit based on their statements about their GLP1 inhibitor by 2026?
4
100Ṁ1052026
38%
chance
1H
6H
1D
1W
1M
ALL
This category of drug is finding more and more uses for a variety of conditions, but the history of drugs, and weight loss drugs in particular, is legally fraught (Phen-Fen, etc.) Are we irrationally exuberant about GLP1 or is it different this time?
This question is managed and resolved by Manifold.
Get 
1,000 to start trading!
1,000Sort by:
How long do we think this will take to resolve and will we learn for how much?
People are also trading
Related questions
Will one of the GLP agonist drugs (eg Semaglutude/Wegovy Tirzepatide/Mounjaro) have a black box warning by 2025
7% chance
Will a majority government owned company introduce a new GLP-1 drug before 2040?
15% chance
Will a GLP-1 agonist diabetes / weight loss drug be the top bestselling drug in 2025?
30% chance
By 2029, will there be an FDA approval of GLP-1 for a substance use disorder?
86% chance
Will Lantern Biotech get sued for over $1M by 2029?
31% chance
Will a GLP-1 receptor agonist (Ozempic-like drug) be added to public water supplies in the United States by 2075?
15% chance
Ozempic will NOT be the leading GLP-1 agonist by total $ US sales by December 31, 2025
42% chance
[M$5k subsidy] Will any FDA-approved GLP-1 agonists be withdrawn from the market for safety reasons by...
Will a large insurance company cover weight loss drugs before 2027?
91% chance
Will Ozempic/GLP-1 Agonists become an issue with a clear partisan divide in the US in the next 5 years?
39% chance